To evaluate the interplay between obesity and reproductive health, emphasizing the significance of understanding mechanisms of male and female infertility related to obesity and exploring potential therapeutic interventions.
Key Findings:
Obesity leads to male obesity-related secondary hypogonadism (MOSH) and female obesity-related secondary hypogonadism (FOSH), with significant implications for fertility.
Even metabolically healthy obese women are at increased risk for infertility, highlighting the need for targeted interventions.
Weight loss is crucial for fertility preservation, and GLP-1 receptor agonists may offer additional reproductive benefits, as supported by emerging research.
Interpretation:
The review underscores the importance of addressing obesity to improve reproductive health outcomes, emphasizing the need for integrated metabolic and reproductive health strategies that can be implemented in clinical settings.
Limitations:
The review may not encompass all recent studies on obesity and reproductive health, particularly those published in the last year.
Potential biases in the selection of studies and interpretations of findings could affect the overall conclusions drawn.
Conclusion:
Managing obesity is essential for reproductive health, and GLP-1 receptor agonists represent a promising avenue for enhancing fertility beyond weight loss, warranting further research to explore their full potential.
